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Background:   The decline in cardiorespiratory fitness and lung function was higher in smokers. Training method could 
mitigate some of the negative consequences of smoking among smokers unable or unwilling to quit. 
Objective: To examine the effects of continuous training on lungs functional capability and cardiorespiratory fitness in 
smokers. 
Methods:  Fifteen cigarette smokers, 14 hookah smokers, and 14 nonsmokers were assigned to low-intensity continuous 
training (20-30 minutes of running at 40% of maximum oxygen uptake (VO2max). Lung function and cardiorespiratory fit- 
ness parameters were determined using respectively spirometer and treadmill maximal exercise test. 
Results: Continuous training improved forced expiratory volume in one second (FEV1) and forced expiratory flow at 50% of 
FVC (FEF50 %) in all participants, smokers and nonsmokers (p < 0.05). In contrast, forced vital capacity (FVC) im- 
provement was significant only among cigarette smokers (CS) (+1.7±2.21%,  p < 0.01) and hookah smokers (HS) (+1.3±1.7 
%, p < 0.05). Likewise, an improvement in cardiorespiratory fitness in both smokers groups without significant changes in 
diastolic blood pressure (DBP) for CS group and in velocity at maximum oxygen uptake (vVO2max) for HS group. 
Conclusion: The low-intensity continuous training improves cardiorespiratory fitness and reduces lung function decline in 
both cigarette and hookah smokers. It seems to be beneficial in the prevention programs of hypertension. It could have 
important implications in prevention and treatment programs in smokers unable or unwilling to quit. 
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The decline in fitness and lung function was significant- ly 
higher in smokers than in nonsmokers and could not be 
explained by differences in age and physical activity1. 
Smoking is the biggest risk factor involved in the decline of 
lung function. In this context, several authors have 
found that smoking reduces the forced expiratory vol- 
ume in one second (FEV1), forced vital capacity (FVC)




Laboratory of Pharmacology, 
Sfax Medicine Faculty SMF, 
Avenue Majida Boulila, Sfax 3029, Tunisia. 
E-mail: abdessalemkoubaa@gmail.com 
Tel: 00 216 20 386 968 
Fax : 00 216 74 278 502 
The cigarettes or hookah consumption has risks of ad- 
diction, illness or death. Koubaa et al.5 assessed the 
harmful effects of hookah consumption compared to 
cigarette smokers in sedentary adult’s subjects by meas- 
uring biochemical and cardiorespiratory  parameters. 
This study reinforces the evidence that hookah con- 
sumption was associated with exposure to toxic sub-




stances and harmful effects on cardiopulmonary func- 
tion and antioxidant defense capacity and produced in 
some cases, the same effects as the cigarettes. Many pre- 
vious studies suggest that smoking hookah has adverse 
effects similar to cigarettes6-8. 
 
The findings of  Saetta et al.9  indicate that cigarette 
smoke affects not only the airways, but also the lung 
parenchyma and pulmonary arteries, causing irreversi- 
ble obstruction of the branches. The main risk factor 
for this obstruction is smoking. Thus, and according 
to a Swedish study that was interested in subjects aged 
over 76 years, nearly 66.7% of smokers presented with a 
chronic obstructive pulmonary disease (COPD). This 
data suggests that COPD is a disease that affects the 
majority of smokers when they live long enough10. This 
pathology, according to WHO statistics11, is the cause 
of death that will increase more in industrialized coun- 
tries and will become the third leading cause of death 
in 2020. In Tunisia, the death rate from smoking-related 
COPD is 84 % in men and 35% in women12. 
 
Undoubtedly, the inhalation of cigarette or hookah 
smoke is associated with hypertension (HT), an in- crease 
in resting heart rate (HR) and at exercise and a decreased 
tolerance to the effort13. These effects are important 
firstly via the nicotine which causes an in- crease in 
myocardial oxygen demand and, secondly, by the 
functional anemia induced by the increased uptake of 
carbonmonoxide on the hemoglobin14. Therefore an 
increased tachycardia, decreased maximal oxygen con- 
sumption and harmful effect on peripheral muscle 15,16 
with early anaerobic threshold17. These different effects 
result in reduced of effort tolerance18,19. 
 
In order to prevent and slow the progression of hy- 
pertension and improve health and cardiorespiratory 
performance, several previous studies have suggested 
that physical activity can play a central role20-23. In this 
context, the Canadian medical association indicated 
that regular moderate physical activity (40% to 60% of 
VO2max) for 50 to 60 minutes, 3-4 times a week was  
 
recommended in the prevention or treatment of hyper- 
tension24.Fagard et al.22 confirm these results, showing a 
significant reduction in systolic blood pressure (SBP) 
and diastolic blood pressure (DBP) for a repeated 
exercise 3-5 times per week for 30 to 60 min and 40% 
to 50% of  VO2max. In addition, other studies using 
different training periods showed significant 
improvements in VO2max and in the rate of 
spontaneous walking20 and a significant decrease in 
fatigue, and an improvement of physical ability and life 
quality21. 
Exercise may have the potential to mitigate some of the 
negative consequences of smoking. Some studies, sug- 
gest that training at vigorous exercise intensity (60-85% 
of reserve heart rate) can be a useful aid to stop smok- 
ing25,26. To our knowledge there’s lack of empirical evi- 
dence documented that such a method of physical ac- 
tivity has beneficial effects on physiological symptoms 
of smokers. Therefore, there is a need to expand the 
range of potentially effective harm reduction strategies 
among smokers unable or unwilling to quit smoking. 
 
We would like discover a physical activity method to be- 
come a strategy so that it can improve cardiopulmonary 
performance and delay the lung function decline caused 
by smoking. It seems therefore important to assess 
through a co- hort study, the low-intensity continuous 
training effects on cardiorespiratory performance and 





A total of forty-three sedentary and healthy male smok- 
ers and non-smokers from the general community of 
Tunisia, which belongs to the public function (profes- 
sion does not require physical exertion), volunteered to 
participate in this study and were recruited within 
pharmacology laboratory of the Faculty of Medicine, 
University of Sfax, Tunisia. The anthropometric char- 
acteristics of participant are shown in [Table 1].















p = 0.82 
p = 0.75 
74.1±4.4 74.3±2.3 74±3.5 p = 0.97 
24.1±1.8 24±1 24.1±1.2 p = 0.99 
 


















NS = nonsmokers; CS = cigarettes smokers; HS = hookah smokers; BMI = body mass index. 
 
 
Participants were admitted to the training program after 
approval by a cardiologist physician. They were 
normolipidemic (fasting triglycerides<1.7 mmol/L), 
nonobese. No subject used nutritional supplements or 
medications. Presence of any kind of disease (based on 
history, medical examination, and exercise stress 
testing), or FEV1/FVC% < 70%27,28, or involvement in 
regular physical activity or exercise program for the 12- 
month period preceding the visit day, were also 
exclusion criteria. On the basis of these criteria, 9 
subjects from 52 were excluded. Eventually, 43 subjects 
were included in subsequent tests and they were 
admitted to the training program. 
 
After receiving a complete verbal description of proto- 
col, risks and benefits of the study, subjects provided 
written consent to an experimental protocol approved 
by the Research Ethics Committee of the Faculty of 
Medicine, University of Sfax, Tunisia. Smokers were in- 
structed to refrain from smoking at least one hour prior 
to reporting to the laboratory as suggested by Dietrich 
et al.29  
 
Cigarette and hookah smokers were recruited accord- 
ing to the number of cigarettes and hookah per day and 
how long they had been smoking. We considered 
cigarette smokers all subjects with consumption greater 
or equal to 10 pack-years (PY) and an average score of 
tobacco dependence of 8.12 ±1.41, measured by the 
Fagerström nicotine dependence test30. We quantified 
hookah consumption, as in the study of Kiter et al.31, in 
hookah- years (HY) and kg of cumulative tobacco. The 
tobacco used in a single hookah session weighs be 
tween 10 and 25 grams32. Regular hookah smokers are 
those having tobacco consumption greater or equal to 5 
hookah- years (HY)33.  
 
 
Participants were divided into three groups, and they 
performed a low-intensity continuous training program 
3 times a week for 12 weeks. A cigarette smokers group 
(CS) (n= 15); a hookah smokers group (HS) (n = 14) 
and another nonsmokers group (NS) (n = 14). All 
subjects were subjected to a spirometric assessment and 
physical test session before and after the training 
program. The session includes lung function and 
treadmill maximal exercise test. All these measurements 




Body weight was measured to the nearest 100 grams 
with a calibrated electronic scale (TANITA TBF.350 
model), and height was measured to the nearest 1mm 
with a fixed stadiometer. Body mass index (BMI) was 
calculated with the formula: [BMI (kg.m-2) = Weight 
(kg) / Height2 (m2)]. 
 
Calculation of recovery index 
Heart rate was recorded every minute during 5 minutes 
after the exercise test. 
Calculation of recovery index is based on two data: 
Calculation of the regression index and the correlation 
index. 
Recovery index = Regression index x correlation Index 
 
Lung function assessments 
A portable spirometer (MIR Spirobank G USB Spirom- 
eter, Rome, Italy) was used to assess smokers lung func- 
tion. Standard procedure requires forced vital capaci- 
ty (FVC) and forced expiratory volume in one second 
(FEV1) and should be measured from a series of at least 
three forced expiratory curves34. This study required- 
participants to perform three correct manoeuvres. Par- 
ticipants completed the spirometry assessment seated





with a nose clip attached, the mouthpiece is placed into 
the mouth, lips and teeth around the mouthpiece to 
form a tight seal and breathe out hard and quickly until 
all air is expelled. 
It is vital that participants inhale completely, to total 
lung capacity, and continue to exhale until they have 
fully emptied their lungs (to residual volume). Pulmonary  
function variables included: FVC, FEV1, FEV1,FVC 
  ratio, FEF50% and FEF25-75%. Results were   
  expressed as percentages of the predicted value to    
  allow comparison of results across participants. 
 
 
Physical fitness assessment 
V̇O max and max heart rate measurements during exer- 
cise were examined through treadmill maximal exercise 
test (COSMED Pulmonary-Function Equipment 37 
Via dei Piani di monte Savello I-00040 Rome ITALY). 
This dynamic and maximum test, untilfatigue, consists in 
increasing the speed of  1kmh-1  every 2 min, after 
warm up of 5 min with a 6 kmh-1 speed until the par- 
ticipant could no longer continue. V̇ O2  max is reached 
when oxygen consumption remains at steady state de- 
spite an increase in workload. Heart rate using (Polar 
Electro Oy, Kempele, Finland) was monitored through- 
out the test and was recorded at the conclusion of every 
two-minute stage. The oxygen consumption (V ̇ O2) was 
continually recorded and measured in real time using 
oxygen analyzer (Fitmate, version 1.2 PRO COSMED). 
At the end of the test a detailed report will be printed. 
Verbal encouragement was provided throughout the 
test to ensure that the maximal effort was achieved. 
 
Continuous training protocol 
Subjects of three groups underwent a continuous train- 
ing program during a 3-months period.  Training was 
performed continuously for 20 minutes (first month), 
25 minutes (second month)  and  30 minutes (third 
month), three times per week at an intensity of  40% 
of V̇ O2max, on race track of 400 m at the Institute of 
Sport of Sfax, Tunisia. The cones placed and spaced 20 
meters on a race track. At each beep, the subject must 
reach the following cone. All warm-ups before training 
should be between 50% and 60% of maximum heart 
rate for a period of about 10 minutes. 
It was asked of participants to run with a continuous 
rhythm respecting sound beeps and the requested time 
throughout the training session. The training load was 
insured by time and traveled distance and controlled by 
sound beeps. (T: the time between two cones; d: dis- 
tance between two cones; V: proposed velocity). The 
load increase during the training period was provided 
by the increase in working time and the distance cov- 
ered in each session. All participants  successfully com- 
pleted the training period and no absences were record- 
ed during all sessions. In addition, we have verified that 
there was no involvement in physical activity or exercise 
program throughout the 12-week training period. 
 
Statistical analysis 
All statistical tests were processed using STATISTICA 
Software (StatSoft, France). The data was expressed as 
mean ± SD (standard deviation). After normality verifi- 
cation with the Shapiro-Wilk’s w test, and homogeneity 
of  variances with Levene’s test, parametric tests were 
performed. One-way  ANOVA was used to  indicate 
inter group differences in the baseline subjects’ char- 
acteristics. Inter and intra-group comparisons of  the 
variables were made by two-way ANOVA (group vs. 
training) with repeated measurements. Least Significant 
Different (LSD) post-hoc analysis was used to identi- 
fy significant group differences that were indicated by 
one-way and two-way ANOVA. A probability level of 




Before and after training, we did not observe any sig- 
nificant difference in body-weight and BMI values be- 
tween the nonsmoker and smoker groups (Table 2).
 
 




                        ns = not significant, p > 0.05






















BMI (kg.m-2) 24.1±1.8 24±1 24.1±1.2 24±1.3 24.1±0.9 24.1±1 ns 
 




However, most of the spirometric values were higher in 
all of non-smokers subjects and significantly different 
to those of cigarette and hookah smokers before our 
training program. We reported in table 3 the spiromet- 
ric values in percentages of the predicted value of our 
entire population before training.
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p = 0,035 
 
FEF25-75% 

















p < 0,001 
 
 
p = 0,005 
FVC = forced vital capacity; FEV1= forced expiratory volume in one second; PEF= peak expiratory 
flow; FEF50% = forced expiratory flow at 50% of FVC; FEF 25%-75% = forced expiratory flow at 25 to 
75% of FVC; *, **, *** = significant difference compared with nonsmokers at p < 0.05; p < 0.01; p < 
0.001 respectively; # = significant difference compared with cigarettes smokers at p < 0.05. 
 
 
Compared to nonsmokers group, ANOVA showed sig- 
nificant differences for all measured parameters. For 
explored values of FVC, PEF and FEF 25-75%, statis- 
tical analysis showed no difference among cigarette and 
hookah smokers. 
 
Application of  LSD post-hoc test showed a similar 
significant difference (p <0.05) in FEV1, FEV1/FVC, 
and FEF 50% of CS subjects compared to HS subjects. 
Furthermore, the FEV1 of CS group tends to be lower 
than of NS group, but the difference was not signifi- 
cant. The HS group also showed a low level of FEF 
50% compared to the two groups CS (P < 0.05) and 
NS (P < 0.01). 
 
 
Training effect on lung function 
The improvement rate in the respiratory functional 
exploration results after the training period, is summa- 
rized in table 4.




Table 4. Improvement rate (Δ) of respiratory parameters of the three groups (NS, CS, HS). 
 
 
Parameters  Means ± SD  
 
ANOVA 













p < 0,001 
p = 0,005 
PEF (%) 109.58±4.4 102.9±4.6** 100.9±5.7*** p < 0,001 
FEV1/FVC (%) 99.12±5.6 107.45±7.5* 100.45±9.2# p = 0,035 
FEF25-75% (%) 101.92±7.1 92.8±5.4*** 90.8±3.3*** p < 0,001 




FVC = forced vital capacity; FEV1= forced expiratory volume in one second; PEF= peak expiratory 
flow; FEF50% = forced expiratory flow at 50% of FVC; FEF 25%-75% = forced expiratory flow at 
25 to 75% of FVC; ns = not significant; †, ††= significant difference in Pre vs. Post program at p < 
0.05; p < 0.01, respectively. 
 
 
                              
The three-month continuous training period, induces 
changes in respiratory parameters, however, they vary 
according to the group. This change did not show sig- 
nificant differences in PEF, FEV1/FVC and FEF 25- 
75% measured after the training period. 
 
 
The training period produces an increase in FVC of all 
our participants; however, this improvement was signif- 
icant only among smokers. It is of the order of +1.7 
± 2.21% (p <0.01) for CS group and +1.3 ± 1.7% (p 
<0.05) for HS group. In addition,  all our subjects ben- 
efited a significant increase in FEV1  after the training 
program (Table 3). Thus, the improvement was +1.83 ± 
2.69% of NS group (p <0.05), +1.9 ± 2.13% (p <0.05) 
in CS group and +1.7 ± 2% (p <0.05) for the HS group. 
The FEF 50% of the three groups NS, CS and HS fol- 
lows the same trend as the FEV1, with significant dif- 
ferences (p <0.05), representing increases of +1.08 ± 
2.19%, +1 ± 2.36% and +1.6 ± 2.5%, respectively. 
 
 
Training effect on cardiorespiratory fitness 
The results of maximal exercise test of the three groups 
before training period are summarized in table 5.









 Means ± SD   
ANOVA 
NS CS HS 
Resting HR (bpm) 82,08±4,6 88,8±4,2*** 90,7±3*** p < 0,001 
SBP (mm Hg) 124,33±7,1 140,2±3,1*** 143,2±4,7*** p < 0,001 
DBP (mm Hg) 84,25±6,8 91,1±2,4** 93,4±3,4*** p < 0,001 
vVO
2




















p < 0,001 




17,9±0,8 17,31±1 15,99±1***## p < 0,001 
HR = heart rate; bpm = beats per minute; SBP = systolic blood pressure; DBP = diastolic 
blood pressure; vVO2max = velocity at maximum oxygen uptake; VO2max = maximum oxygen 
uptake; **, *** = significant differences compared to nonsmokers at p < 0.01, p < 0.001 




The (LSD) post-hoc test showed that the two groups 
CS and HS had resting HR, SBP and DBP similar and 
significantly  higher than those of  nonsmokers (p < 
0.001). Similarly, no significant difference in these val- 
ues was revealed between the two smoker groups. 
 
 
Regarding the V̇O2max, vV̇ O2max and recovery index, 
the statistical analysis showed significant differences be- 
tween the two smoking groups (p < 0.001, p < 0.001 
and p < 0.01, respectively). Similarly, we have registered 
in the values of  vV̇ O2max and V̇ O2 max, significant 
differences between smoker and nonsmoker groups (p 
< 0.001). The recovery index was better in nonsmokers 
compared to cigarette smokers (p < 0.001) and in ciga- 
rette smokers versus hookah smokers (p < 0.01). 
 
After  the  continuous  training  period,  participants 
showed different improvements (Table 6). Significant 
changes in resting HR for the three groups NS, CS and 
HS were observed after training, with declines of -1.75 
± 2 bpm (P <0.05), 2.5 ± 3 4 bpm (P <0.01) and -2.2 
± 3.1 bpm (P <0.05), respectively. Similarly, there was a 
decrease of SBP for both smoker groups (P <0.05). In 
contrast, the decrease in DBP was significant only for 
the HS group (P <0.01), by a decrease of -2.4 ± 3.4 (mm 
Hg). 
 
The low-intensity continuous training induced also sig- 
nificant increases of  vVO2max for subjects of  NS and 
CS groups and VO2max for the subjects of the CS 
and HS groups. Finally, the recovery index results 
showed most improved recoveries for the subjects of 
the three groups (NS: + 0.44 ± 0.4; CS: + 0.47 ± 0.6; 
HS: + 0 98± 0.8).

















Resting  HR (bpm) 
 










p < 0,001 
p < 0,001 
DBP (mm Hg) 84,25±6,8 91,1±2,4** 93,4±3,4*** p < 0,001 
vVO2max   (km.h
-1





) 39±0,7 35,78±0,9*** 34,35±0,8***### p < 0,001 
Recovery index 17,9±0,8 17,31±1 15,99±1***## p < 0,001 
 















                      HR = heart rate; bpm = beats per minute; SBP = systolic blood pressure; DBP = diastolic blood pressure; 
                      vVO2max = velocity at maximum oxygen uptake; VO2max = maximum oxygen uptake; ns = not significant;  
                     †, ††, ††† = significant differences in Pre vs. Post training program at p < 0.05, p < 0.01, p < 0.001, respectively.
 
Discussion 
Sedentary lifestyle, decline of lung function and low 
cardiorespiratory capacity are recognized as the main 
predictors of  morbidity35 and mortality36,37. Indeed, 
several studies have examined, using different proto- 
cols in different cases, the effect of exercise training 
on aerobic capacity and lung function. However, to our 
knowledge,  no study has determined the effect of a 
continuous training program on these capacities among 
male adults unable or refuse to quit smoking. In fact, 
the aim of our study was to determine the contribution 
of 12-week low-intensity continuous training on lung 
function performance and aerobic fitness in cigarette 
and hookah smokers. Data of this study show the 
relationship between physical activity, cardiorespiratory 
capacity and lung function in healthy male, smokers and 
non-smokers. 
 
The low-intensity continuous training was strongly as- 
sociated with better values of the treadmill maximal 
exercise test. This finding was consistent with other 
studies38,39. This study revealed considerable changes 
in VO2max and recovery index of all smoker partici- 
pants. However, in the HS group, we found a greater 
improvement of two recorded values (see Fig. 1). In 
this context, Daussin et al.40 showed a significant in- 
crease in VO2max of the subjects who participated in a 
continuous training program for 8 weeks. Our findings 
support the results of MacDougall et al.38, Harmer et 
al.39, Macfarlane et al.41, Tijonna et al.42 and Daussin et  
al.40 who reported significant increases in VO2max 
values after various training programs. In contrast, a 
related study that was conducted by Mazoochi et al.43 
showed no continuous training effect on VO2max. The 
results of this study can be confirmed by those of Denis 
et al.44.
 
Fig 1. Improvement rate in percentage (Δ%) of cardiorespirory parameters in Pre vs. Post program





On the other hand, low-intensity continuous training 
induced a significant decrease in blood pressure and 
resting HR. The result is a significant reduction in SBP 
of  -2% for CS group and -1.8% for the HS group, 
and only significant decrease of -2.5% of DBP in HS 
group (Fig.1). These favorable changes resulting from 
the continuous training on this two recorded values are 
in agreement with studies of Lawal & Kankanala45 and 
Laterza et al.46 and different from conclusions of Ferri- 
er et al.47. Similar results to our findings were reported 
by Westhoff et al48. Their findings show a significant 
decrease in SBP and DBP of - 8.5 ± 8.2 mm Hg and 
- 5.1 ± 3.7 mm Hg, respectively. This partial difference in 
results may be explained in part by the implemented 
protocols diversity (Training methods, protocol dura- 
tion, participants' age, smoking habits etc.) and the indi- 








Exercise is an important component of pulmonary re- 
habilitation and may be associated with physiological 
and psychological benefits49. Although the respirato- 
ry rehabilitation programs improve the quality of  life 
and some physiological  measures, the improvements 
in FEV  levels were not reported consistently2. In our 
study, all participants, smokers and nonsmokers had 
higher levels of FEV1 and FVC after this continuous 
training program. The improvement was about +2% 
and from +0.9% to +2%,  respectively (Fig.2). Our 
results confirm the findings of Mehrotra et al.50, who 
reported that lung function was better in most active 
subjects than sedentary subjects. However, there was 
no significant difference of FEV1/FVC in Pre vs. Post 
program. This is explained by the pulmonary efficiency 
weakness of our participants. These results are consist- 
ent with the findings of Cheng et al.51. 
 
 
The cigarette smoker participants who had the lowest 
FVC before training protocol, tended to have the best 
improvement among the three groups after training (≈ 
+2%). This may suggest that the respiratory system re- 
sponse to physical activity among CS group is higher 
than in HS or NS groups. 
 
In summary, our analysis suggests that a low-intensity 
continuous training program was associated with an im- 
proved cardiorespiratory fitness and aspect of physio- 
logical wellness. This improvement was more marked in 
smokers than in nonsmokers, but the respiratory func-




tion change contributed little to this association for all 
participants after 12-weeks training. 
 
Conclusion 
The present study demonstrates that low-intensity con- 
tinuous training improves cardiorespiratory fitness. 
Intensity and training volume have been closely mon- 
itored to demonstrate the continuous exercise impor- 
tance in reducing lung function decline in cigarette and 
hookah smokers. Likewise, physical training with con- 
tinuous exercises seems to be beneficial in hypertension 
prevention. Finally, these results could have important 
implications in prevention and treatment programs in 




- Smokers before training have a reduced lung function 
and worst cardiorespiratory fitness compared with no 
smokers. 
- Significant improvements in FEV1   and FEF50 % 
among smokers and nonsmokers after training. 
- Significant improvements in FVC only in smokers 
- Improvement in cardiorespiratory capacity is signifi- 
cantly higher in smokers than in nonsmokers. 
- Smokers unable to quit smoking could focus at prac- 
ticing leisure time physical activity regularly to reduce 
the decline of lung function and cardiorespiratory ca- 
pacity. 
 
Limitations of the study 
The lack of a control group may be considered a limi- 
tation of the present study (smokers group follow the 
same daily activity during the same training period). I 
also think that future research should include a group 
of passive smokers. Likewise, the relatively small sam- 
ple size could have limited our ability to detect group 
differences in the chosen parameters. This is indeed a 
limitation of this work, and should be considered rela- 
tive to our findings. 
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